Penserra Capital Management LLC Vir Biotechnology, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$30.97 - $54.03 $92,600 - $161,549
-2,990 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$34.9 - $54.54 $1,047 - $1,636
30 Added 1.01%
2,990 $130,000
Q2 2021

Aug 12, 2021
BUY
$38.75 - $51.0 $2,712 - $3,570
70 Added 2.42%
2,960 $139,000
Q1 2021

May 13, 2021
SELL
$26.34 - $83.07 $790 - $2,492
-30 Reduced 1.03%
2,890 $148,000
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $74,489 - $126,669
2,920 New
2,920 $78,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email